Rapport Therapeutics, Inc. · NASDAQ:RAPP
Yeleswaram Krishnaswamy sold 360 Rapport Therapeutics, Inc. shares (Form 4)
Traded Apr 8, 2026 · Filed Apr 9, 2026
On Apr 8, 2026, Yeleswaram Krishnaswamy (Chief Development Officer) sold 360 Rapport Therapeutics, Inc. shares at US$34.90 for US$12,564 under a trading plan, leaving 286,516 shares. Filed Apr 9, 2026 (Form 4).
- Sold
- 360 shares
- Price
- US$34.90
- Value
- US$12,564
- Holding after
- 286,516 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Development Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 8, 2026 | Common Stock | Sale | 360 | US$34.90 | 286,516 | Direct |
Source
Related
- Rapport Therapeutics, Inc.
- Yeleswaram Krishnaswamy
- Rapport Therapeutics, Inc. shareholders
- Form 4 · Yeleswaram Krishnaswamy · Aug 26, 2026
- Form 4 · Yeleswaram Krishnaswamy · Aug 20, 2026
- Form 4 · Yeleswaram Krishnaswamy · Apr 21, 2026
- Form 4 · Yeleswaram Krishnaswamy · Apr 14, 2026
- Form 4 · Maraganore John · Oct 22, 2026
- Form 4 · Silva Paul M · Oct 22, 2026
- Form 4 · Young Wendy B. · Oct 22, 2026
- Form 4 · Paul Steven M · Oct 22, 2026
- Form 4 · Ignelzi Troy A. · Oct 21, 2026